Drug Development Research

Papers
(The H4-Index of Drug Development Research is 22. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Androgen sensitivity gateway to COVID‐19 disease severity118
Telmisartan as tentative angiotensin receptor blocker therapeutic for COVID‐1969
Potential antiviral activity of isorhamnetin against SARS‐CoV‐2 spike pseudotyped virus in vitro51
Surface receptor‐mediated targeted drug delivery systems for enhanced cancer treatment: A state‐of‐the‐art review43
Epigallocatechin gallate and theaflavin gallate interaction in SARS‐CoV‐2 spike‐protein central channel with reference to the hydroxychloroquine interaction: Bioinformatics and molecular do43
Challenges of peptide and protein drug delivery by oral route: Current strategies to improve the bioavailability41
Synthesis, biological evaluation, and in silico study of novel library sulfonates containing quinazolin‐4(3H)‐one derivatives as potential aldose reductase inhibitors39
Role of mineralocorticoid receptor antagonists in kidney diseases38
Evaluation of hyaluronic acid nanoparticle embedded chitosan–gelatin hydrogels for antibiotic release32
Medicinal chemistry of anthranilic acid derivatives: A mini review29
Revisiting potential druggable targets against SARS‐CoV‐2 and repurposing therapeutics under preclinical study and clinical trials: A comprehensive review28
Snake venom‐derived bradykinin‐potentiating peptides: A promising therapy for COVID‐19?26
Bergenin inhibits bladder cancer progression via activating the PPARγ/PTEN/Akt signal pathway25
Paeoniflorin inhibited nod‐like receptor protein‐3 inflammasome and NF‐κB‐mediated inflammatory reactions in diabetic foot ulcer by inhibiting the chemokine receptor CXCR225
In vitro enzymatic evaluation of some pyrazolo[1,5‐a]pyrimidine derivatives: Design, synthesis, antioxidant, anti‐diabetic, anti‐Alzheimer, and anti‐arthritic activities with molecular modeling24
Hybrid molecules based on 1,3,5‐triazine as potential therapeutics: A focused review24
Neuroprotective mechanisms of mangiferin in neurodegenerative diseases23
Smoking and COVID‐19: Similar bronchial ACE2 and TMPRSS2 expression and higher TMPRSS4 expression in current versus never smokers22
Review of registered clinical trials for the treatment of COVID‐1922
Ginsenoside Rg3 attenuates ovariectomy‐induced osteoporosis via AMPK/mTOR signaling pathway22
A new exploration toward adamantane derivatives as potential anti‐MDR agents: Design, synthesis, antimicrobial, and radiosterilization activity as potential topoisomerase IV and DNA gyrase inhibitors22
Targeting cyclooxygenase enzyme for the adjuvant COVID‐19 therapy22
In vitro–in vivo evaluation of tetrahydrozoline‐loaded ocular in situ gels on rabbits for allergic conjunctivitis management22
0.15438508987427